🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.17
+0.16 (0.48%)
Nov 18, 2026, 1:41 PM EST - Market open

HRMY Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
989.36868.45714.73582.02437.86305.44
Revenue Growth
19.79%21.51%22.80%32.93%43.35%91.21%
Cost of Revenue
256.94198.34156.82121.2483.4855.52
Gross Profit
732.42670.11557.92460.79354.37249.92
Selling, General & Admin
275.48272.05221.27192.69163.3132.03
Research & Development
237.58189.59145.8376.0670.8930.37
Operating Expenses
513.06461.64367.09268.76234.19162.39
Operating Income
219.36208.47190.83192.03120.1987.53
Interest Expense
-12.91-14.65-17.5-23.76-18.8-24.19
Interest & Investment Income
27.1121.9218.5414.733.130.22
Other Non Operating Income (Expenses)
-0.6-0.68-0.070.160.170.02
EBT Excluding Unusual Items
232.96215.06191.8183.16104.6963.57
Other Unusual Items
----9.77--26.15
Pretax Income
232.96215.06191.8173.4104.6937.43
Income Tax Expense
54.3656.3846.3144.54-76.782.83
Net Income
178.6158.69145.49128.85181.4734.6
Net Income to Common
178.6158.69145.49128.85181.4734.6
Net Income Growth
-3.81%9.07%12.91%-28.99%424.52%-
Shares Outstanding (Basic)
585757595958
Shares Outstanding (Diluted)
595958606159
Shares Change
0.57%1.17%-4.15%-1.19%3.19%129.72%
EPS (Basic)
3.082.762.562.173.070.60
EPS (Diluted)
3.022.712.512.132.970.58
EPS Growth
-4.53%7.97%17.84%-28.28%412.07%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
322.93347.89218.67219.08144.2998.26
Free Cash Flow Per Share
5.485.943.783.632.361.66
Gross Margin
74.03%77.16%78.06%79.17%80.93%81.82%
Operating Margin
22.17%24.01%26.70%32.99%27.45%28.66%
Profit Margin
18.05%18.27%20.36%22.14%41.45%11.33%
Free Cash Flow Margin
32.64%40.06%30.59%37.64%32.95%32.17%
EBITDA
244.7233.8214.94216.39143.57106.37
EBITDA Margin
24.73%26.92%30.07%37.18%32.79%34.83%
D&A For EBITDA
25.3425.3424.1124.3623.3918.84
EBIT
219.36208.47190.83192.03120.1987.53
EBIT Margin
22.17%24.01%26.70%32.99%27.45%28.66%
Effective Tax Rate
23.33%26.21%24.14%25.69%-7.56%
Advertising Expenses
-29.5327.5621.5422.4319.56
SEC Filings: 10-K · 10-Q